NNVC
NANOVIRICIDES, INC.Company Information
- Company Name
- NANOVIRICIDES, INC.
- CIK
- CIK0001379006
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- NNVC: NYSE
- Fiscal Year End
- June 30
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- NNVC
SEC filing data through
Insider Sentiment
- Last purchase
- 2015-11-11
- Last sale
- 2013-10-21
- Shares purchased (TTM)
- 469,212
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 2,373,352
- Shares outstanding
- 21,609,488
- Ownership
- 10.98%
Earnings Market Reaction
- Filing date
- 2026-09-28
- Price on filing date
- —
- 1-month reaction
- Pending
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Convertible Preferred Stock | - | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | ||||||
| Nonrelated Party | - | -0 | -0 | 0 | 0 | 0 | -0 | 1 | 0 | 0 | 0 | 0 | ||||||
| Related Party | - | -0 | 0 | 1 | 0 | -0 | -0 | 1 | 1 | -0 | 0 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 3 | 3 | 5 | 1 | 2 | 3 | 4 | 4 | 5 | 3 | 5 | 7 | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 3 | 3 | 5 | 1 | 2 | 3 | 4 | 4 | 5 | 4 | 5 | 7 | ||||||
| Property Plant And Equipment Net | 6 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 8 | 8 | 8 | 8 | ||||||
| Intangible Assets Net Excluding Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Other Assets | ||||||||||||||||||
| Assets | 10 | 10 | 12 | 8 | 9 | 10 | 12 | 12 | 13 | 11 | 13 | 15 | ||||||
Liabilities | ||||||||||||||||||
| Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | ||||||
| Long Term Notes Payable | - | - | - | - | - | - | - | - | - | - | - | 2 | ||||||
Stockholders Equity | ||||||||||||||||||
| Liabilities | - | - | - | - | - | - | - | - | 1 | 1 | 1 | 2 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 166 | 164 | 164 | 158 | 156 | 156 | 155 | 153 | 151 | 148 | 148 | 146 | ||||||
| Retained Earnings Accumulated Deficit | -157 | -155 | -153 | -151 | -149 | -147 | -145 | -143 | -139 | -137 | -135 | -133 | ||||||
| Stockholders Equity | 9 | 9 | 11 | 7 | 8 | 9 | 10 | 10 | 11 | 11 | 12 | 13 | ||||||
| Liabilities And Stockholders Equity | 10 | 10 | 12 | 8 | 9 | 10 | 12 | 12 | 13 | 11 | 13 | 15 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | ||||||
| Common Stock Shares Issued | 23 | 22 | 22 | 18 | 17 | 16 | 16 | 14 | 13 | 12 | 12 | 12 | ||||||
| Shares Outstanding | 23 | 22 | 22 | 18 | 17 | 16 | 16 | 14 | 13 | 12 | 12 | 12 | ||||||
Select a line item above to chart it.
Recent filings
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialNANOVIRICIDES, INC. (NNVC) — SEC Financial Statements & Analysis
NANOVIRICIDES, INC. (NNVC) is a pharmaceutical preparations company, incorporated in DE. NANOVIRICIDES, INC. trades on NYSE as: NNVC. NANOVIRICIDES, INC. (NNVC)'s most recent SEC filing is a Form 10-K for the period ended 2026-06-30, filed with the SEC on 2026-09-28. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), NANOVIRICIDES, INC. carries a market cap of $27.86M, a P/E ratio of -3.39x, a P/B ratio of 3.21x, an enterprise value of $25.06M, and an EV/EBITDA multiple of -3.22x. On profitability, it posts a Return on Equity (ROE) of -101.46%, a Return on Assets (ROA) of -87.91%, and a Return on Invested Capital (ROIC) of -140.22%. Per share, it reports EPS of $-0.41, diluted EPS of $-0.41, free cash flow per share of $-0.39, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -13.19% year-over-year and EPS growth of -34.99% year-over-year. On the balance sheet, it maintains a current ratio of 2.66x, a quick ratio of 2.35x, working capital of $1.97M, a debt-to-equity ratio of 0.14x, a debt ratio of 0.12, an interest coverage ratio of -56339.72x, free cash flow of $-7.78M (TTM), and net debt of $-2.79M. Figures sourced from SEC EDGAR.
- Market Cap
- $27.86M
- P/E TTM
- -3.39x
- EPS TTM
- $-0.41
- P/B TTM
- 3.21x
- ROE TTM
- -101.46%
- ROA TTM
- -87.91%
- Debt To Equity
- 0.14x
- Free Cash Flow TTM
- $-7.78M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is NANOVIRICIDES, INC. in?
NANOVIRICIDES, INC. (NNVC) operates in the Pharmaceutical Preparations industry.
What exchange does NNVC trade on?
NANOVIRICIDES, INC. (NNVC) trades on the NYSE.
Where is NANOVIRICIDES, INC. incorporated?
NANOVIRICIDES, INC. is incorporated in DE.
When was NANOVIRICIDES, INC. (NNVC)'s most recent SEC filing?
NANOVIRICIDES, INC. (NNVC)'s most recent SEC filing is a Form 10-K for the period ended 2026-06-30, filed with the SEC on 2026-09-28.
What is NNVC's market cap?
NANOVIRICIDES, INC. (NNVC) has a market capitalization of $27.86M as of 2026-06-30.
What is NNVC's EPS (earnings per share)?
NANOVIRICIDES, INC. (NNVC)'s trailing twelve month EPS is $-0.41 as of 2026-06-30.
What is NNVC's ROE (return on equity)?
NANOVIRICIDES, INC. (NNVC)'s trailing twelve month Return on Equity (ROE) is -101.46% as of 2026-06-30.
What is NNVC's ROA (return on assets)?
NANOVIRICIDES, INC. (NNVC)'s trailing twelve month Return on Assets (ROA) is -87.91% as of 2026-06-30.
What is NNVC's ROIC (return on invested capital)?
NANOVIRICIDES, INC. (NNVC)'s trailing twelve month Return on Invested Capital (ROIC) is -140.22% as of 2026-06-30.
What is NNVC's EV/EBITDA?
NANOVIRICIDES, INC. (NNVC)'s trailing twelve month EV/EBITDA is -3.22x as of 2026-06-30.